Red cell disorders
Gene: MTR
Clinical features are variable, but include delayed development, megaloblastic anaemia, homocystinuria, and hypomethioninemia, all of which respond to cobalamin supplementation. More than 20 families reported.Created: 10 Sep 2021, 6:28 a.m. | Last Modified: 10 Sep 2021, 6:28 a.m.
Panel Version: 0.96
Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal
Phenotypes
Homocystinuria-megaloblastic anaemia, cblG complementation type, MIM# 250940
Publications
Gene: mtr has been classified as Green List (High Evidence).
Phenotypes for gene: MTR were changed from Homocystinuria-megaloblastic anemia, cblG complementation type, 250940; 250940 Homocystinuria-megaloblastic anemia, cblG complementation type to Homocystinuria-megaloblastic anaemia, cblG complementation type, MIM# 250940
Publications for gene: MTR were set to 9683607; 12068375
Added phenotypes Homocystinuria-megaloblastic anemia, cblG complementation type, 250940; 250940 Homocystinuria-megaloblastic anemia, cblG complementation type for gene: MTR
gene: MTR was added gene: MTR was added to Rare anaemia_GEL. Sources: London South GLH,North West GLH,Expert Review Green,Wessex and West Midlands GLH,NHS GMS,Yorkshire and North East GLH Mode of inheritance for gene: MTR was set to BIALLELIC, autosomal or pseudoautosomal Publications for gene: MTR were set to 9683607; 12068375 Phenotypes for gene: MTR were set to Homocystinuria-megaloblastic anemia, cblG complementation type, 250940; 250940 Homocystinuria-megaloblastic anemia, cblG complementation type